XML 135 R119.htm IDEA: XBRL DOCUMENT v3.23.1
Schedule II - Condensed Financial Information of Registrant Statements of Cash Flows (Details) - USD ($)
$ in Millions
 1 Months Ended 12 Months Ended
Mar. 31, 2021
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Cash flows (used in)/from operating activities:        
Amortization of right-of-use operating lease assets   $ 10.1 $ 12.0 $ 11.8
Interest on operating lease liability   (5.4) (5.5)  
Change in right of lease assets   (6.7) 0.4 12.9
Change in operating lease liabilities   (15.5) (17.5) (17.3)
Net cash (used in)/from operating activities   (55.0) 524.7 (672.7)
Cash flows (used in)/from investing activities:        
Proceeds/(purchases) of short term investments   (7.0) (26.8) (58.3)
Payments for acquisitions and investments, net of cash acquired   (2.0) (3.2)  
(Purchases) of other investments   (62.5) (20.0) 0.0
Net cash (used in)/from investing activities   (196.5) (950.3) 1,151.2
Cash flows used in/from financing activities:        
Net cash (used in)/from financing activities   (84.6) 0.5 223.5
Cash and cash equivalents at beginning of period [1]   1,314.1    
Cash and cash equivalents at end of period (1) [1]   959.2 1,314.1  
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect   (354.9) (433.2) 716.8
Proceeds from sales and maturities of fixed income securities — Trading   293.6 548.2 554.4
Parent Company        
Cash flows (used in)/from operating activities:        
Net income (excluding equity in net earnings of subsidiaries)   36.9 120.3 52.0
Realized and unrealized losses/(gains)   19.7 (6.7) 1.5
(Gain)/loss on derivative contracts   (15.4) 6.2 (0.3)
Amortization of right-of-use operating lease assets   0.5 0.5 0.4
Interest on operating lease liability   0.1 0.1 (0.4)
Change in other assets   2.1 (1.6) 0.5
Change in right of lease assets   0.0 (2.0) 0.0
Change in accrued expenses and other payables   (3.2) 1.4 15.9
Change in intercompany activities   41.1 35.0 41.6
Change in operating lease liabilities   (0.6) 1.5 0.0
Net cash (used in)/from operating activities   81.2 154.7 111.2
Cash flows (used in)/from investing activities:        
(Purchases) of fixed income securities   (10.0) (42.6) 75.6
Investment in subsidiaries   5.0 (115.0) (87.3)
Net cash (used in)/from investing activities   2.8 (157.6) (11.7)
Cash flows used in/from financing activities:        
Net cash (used in)/from financing activities   (84.6) (44.5) (44.5)
Cash and cash equivalents at beginning of period   45.0 92.4 37.4
Cash and cash equivalents at end of period (1)   44.4 45.0 92.4
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect   (0.6) (47.4) 55.0
Proceeds from sales and maturities of fixed income securities — Trading   $ 7.8 0.0 $ 0.0
MVI        
Cash flows (used in)/from investing activities:        
Payments for acquisitions and investments, net of cash acquired $ (0.8)   $ (0.4)  
[1] Cash and cash equivalents includes restricted cash of $232.1 million (2021 — $364.9 million, 2020 — $296.0 million) which are held in trusts.